How Regeneron's Coronavirus Antibody Treatment Differs From Convalescent PlasmaThe Motley Fool • 10/19/20
Regeneron's (REGN) Dupixent Gets Positive CHMP Opinion for DermatitisZacks Investment Research • 10/19/20
Regeneron Reports Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 10/15/20
Regeneron's Antibody Cocktail REGN-EB3 (Inmazeb®) is First FDA-Approved Treatment for Ebola (Zaire Ebolavirus)PRNewsWire • 10/14/20
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug Dupixent's Use In ChildrenBenzinga • 10/13/20
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021Benzinga • 10/08/20
Covid Report: Regeneron Pharmaceuticals Files For Emergency Authorization; Gilead Inks European Supply DealInvestors Business Daily • 10/08/20
Regeneron's stock rallies after it announces EUA request for antibody treatmentMarket Watch • 10/08/20
Regeneron to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call and Webcast on November 5, 2020PRNewsWire • 10/06/20